Anna Almarsdottir

Prof. Anna Almarsdottir


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2010 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
KFKari Furu
Kari Furu
BWBjörn Wettermark
Björn Wettermark
MAMorten Andersen
Morten Andersen
JMJaana E. Martikainen
Jaana E. Martikainen
AAAnna Almarsdottir
Anna Almarsdottir
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen

1 December 2009 in Journal of Child and Adolescent Psychopharmacology
Verified
Journal Article
Closed access
HZHelga Zoëga
Helga Zoëga
GBGísli Baldursson
Gísli Baldursson
BHBirgir Hrafnkelsson
Birgir Hrafnkelsson
AAAnna Almarsdottir
Anna Almarsdottir
UVUnnur Valdimarsdóttir
Unnur Valdimarsdóttir
MHMatthías Halldórsson
Matthías Halldórsson
The aim of this study was to investigate psychotropic drug use among children in Iceland between 2003 and 2007. A nationwide population-based drug use study covering the total pediatric population (ages 0-17) in Iceland. Information was obtained from the National Medicines Registry to calculate prevalence of use by year and psychotropic drug group; incidence by year, psychotropic drug group, child's age and sex, and medical specialty of prescriber; the most commonly used psychotropic chemical substances, off-label and unlicensed use and concomitant psychotropic drug use. The overall prevalence of psychotropic drug use was 48.7 per 1000 Icelandic children in 2007. Stimulants and antidepressants increased in prevalence from 2003 to 2007 and were the two most prevalent psychotropic drug groups, respectively, 28.4 and 23.4 per 1000 children in 2007. A statistically significant trend of declining prevalence (p = 0.00013) and incidence (p = 0.0018) of antidepressant use occurred during the study period. Out of 21,986 psychotropic drugs dispensed in 2007, 25.4% were used off-label. With reference to reports from other European countries, the results indicate extensive psychotropic drug use among children in Iceland between 2003 and 2007. Further scrutiny is needed to assess the rationale behind this widespread use.

1 March 1999 in International Journal of Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
TWTommy Westerlund
Tommy Westerlund
AAAnna Almarsdottir
Anna Almarsdottir
AMArne Melander
Arne Melander

1 October 2003 in Scandinavian Journal of Public Health
Verified
Journal Article
Open access
BHBjorn Evald Holstein
Bjorn Evald Holstein
EHEbba Holme Hansen
Ebba Holme Hansen
PDPernille Due
Pernille Due
AAAnna Almarsdottir
Anna Almarsdottir
Aims: To describe the self-reported medicine use for common health complaints among 11 - 15-year-olds in Denmark during a ten year period, 1988 - 1998. The paper focuses on medicine for headache, stomach ache, cough, cold, nervousness, and difficulties in getting to sleep. Methods: Four cross-sectional surveys of 11 - 15-year-old students in random samples of schools in Denmark, conducted in 1988 (n=1,671), 1991 (n=1,860), 1994 (n=4,046) and 1998 (n=5,205). The surveys were similar with regard to sampling and data collection. Data were collected by self-administered questionnaires in the classroom. Results: A large proportion of 11 - 15-year-olds reported medicine use during the past month. It was most common to take medicines for headache (used by 55% of 15-year-old girls and 36% of 15-year-old boys in 1998) and stomach ache (33% among 15-year-old girls in 1998). Pain reliever use was higher among girls than boys and this sex difference increased with age. There was an upward trend in reported medicine use from 1988 to 1998, in particular regarding medicine for stomach-ache among 13- and 15-year-old girls. A large proportion of girls were frequent users of medicine for headache, stomach-ache, and sleeping difficulties. Conclusion: A high proportion of 11 - 15-year-old girls and boys reported medicine use in relation to common health complaints. The proportion of users increased during the past decade. It is suggested that more information about medicine be built into health education programs in the future.

13 June 2018 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
HSHelene Skjøt‐Arkil
Helene Skjøt‐Arkil
CLCarina Lundby
Carina Lundby
LKLene Juel Kjeldsen
Lene Juel Kjeldsen
DSDiana Mark Skovgårds
Diana Mark Skovgårds
AAAnna Almarsdottir
Anna Almarsdottir
TGTrine Graabæk
Trine Graabæk

1 January 1999 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
TWT. Westerlund
T. Westerlund
AAAnna Almarsdottir
Anna Almarsdottir
AMA. Melander
A. Melander